Philip Lavin Selected Research

Philip Lavin Research Topics

1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Fatty Liver 11/2020
1	Hypercholesterolemia 11/2020
1	Hyperlipidemias (Hyperlipidemia) 11/2020
1	Thrombotic Stroke 11/2020
1	Myocardial Infarction 11/2020
1	Hypersensitivity (Allergy) 01/2020
1	Friedreich Ataxia (Friedreich's Ataxia) 01/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2017
1	Hypokalemia 12/2014
1	Hyperkalemia 12/2014
1	Edema (Dropsy) 12/2014
1	Polyps 04/2014
1	Neoplasms (Cancer) 04/2014
1	Colorectal Neoplasms (Colorectal Cancer) 04/2014
1	Hemorrhage 04/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2011
1	Thrombocytopenia (Thrombopenia) 04/2011
1	Thrombosis (Thrombus) 04/2011
1	Sepsis (Septicemia) 04/2011

1	Oxidoreductases (Dehydrogenase)IBA 11/2020
1	CholesterolIBA 11/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2020
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 11/2020
1	Ezetimibe (Zetia)FDA Link 11/2020
1	LDL CholesterolIBA 11/2020
1	BerberineIBA 11/2020
1	Local Anti-Infective Agents (Antiseptics)IBA 01/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2019
1	isophosphamide mustard (IPAM)IBA 08/2017
1	Etoposide (VP 16)FDA LinkGeneric 08/2017
1	Carboplatin (JM8)FDA LinkGeneric 08/2017
1	sodium zirconium cyclosilicateIBA 12/2014
1	ElectrolytesIBA 12/2014
1	PotassiumIBA 12/2014
1	ZirconiumIBA 12/2014
1	DNA (Deoxyribonucleic Acid)IBA 04/2014
1	propylparaben FDA LinkGeneric 04/2011
1	methylparaben FDA LinkGeneric 04/2011
1	Sodium Citrate FDA LinkGeneric 04/2011
1	Heparin (Liquaemin)FDA LinkGeneric 04/2011
1	Methylene Blue (Methylthioninium Chloride)FDA Link 04/2011
1	Phenobarbital (Luminal)FDA Link 04/2011
1	SolutionsIBA 04/2011

1	Therapeutics 12/2014
1	Catheters 04/2011
1	Renal Dialysis (Hemodialysis) 04/2011